BHVN
$10.78-5.69%
BHVN financial statements
The full income statement, balance sheet, and cash-flow statement for Biohaven Ltd. Common Shares (BHVN), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.
Shares outstanding (point-in-time)
2024-06 94.5M2024-09 101.1M2024-12 102.1M2025-03 102.1M2025-06 105.8M2025-09 105.9M2025-12 150.4M2026-03 150.6M2026-06 151.0M+59.8% over 8 periods
SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.
As-reported fiscal years.
| Line item | Trend | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Income Statement | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| — | — | — | 568M+159.4% | 219M+91.2% | ||
| Research & development | 635M-20.2% | 796M+113.2% | 373M-14.6% | 437M+140.8% | 181M+84.3% | |
| Selling, general & administrative | 110M+23.6% | 89.2M+42.2% | 62.8M-52.0% | 131M+249.8% | 37.4M+133.2% | |
| General & administrative | 110M+23.6% | 89.2M+42.2% | 62.8M-52.0% | 131M+249.8% | 37.4M+133.2% | |
| Operating income | -745M+15.8% | -885M-103.0% | -436M+23.2% | -568M-159.4% | -219M-91.2% | |
| Other non-operating income | 8.00M-79.7% | 39.4M+48.8% | 26.5M+1488.2% | -1.91M-257.9% | 1.21M | |
| Equity-method income | — | — | 0.00 | 0.00-100.0% | 5.26M+226.4% | |
| Pre-tax income | -737M+12.8% | -846M-106.5% | -410M+28.1% | -570M-168.2% | -212M-79.0% | |
| Income tax | 1.44M+96.2% | 735K+153.1% | -1.38M-415.8% | 438K-67.9% | 1.37M | |
| Net income | -739M+12.7% | -846M-107.4% | -408M+28.4% | -570M-166.7% | -214M-80.2% | |
| -$6.86+26.1% | -$9.28-62.0% | -$5.73+55.1% | -$12.75-134.8% | -$5.43-80.4% | ||
| EPS (basic) | -$6.86+26.1% | -$9.28-62.0% | -$5.73+55.1% | -$12.75-134.8% | -$5.43-80.4% | |
| Weighted-avg shares (basic) | 108M+18.0% | 91.2M+28.1% | 71.2M+59.1% | 44.7M+13.6% | 39.4M+0.0% | |
| Weighted-avg shares (diluted) | 108M+18.0% | 91.2M+28.1% | 71.2M+59.1% | 44.7M+13.6% | 39.4M+0.0% | |
| Balance Sheet | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 368M-31.6% | 538M+21.7% | 442M-24.6% | 587M+519.0% | 94.8M | ||
| Cash & equivalents | 230M+132.0% | 99.1M-60.1% | 248M+21.2% | 205M+169.4% | 76.1M-7.8% | |
| Short-term investments | 89.2M-76.9% | 387M+190.0% | 133M-48.8% | 260M | 0.00 | |
| Prepaid expenses | 47.0M-4.8% | 49.4M+40.1% | 35.2M+68.3% | 20.9M+211.0% | 6.73M | |
| Other current assets | 2.17M-30.1% | 3.10M-74.4% | 12.1M-37.2% | 19.3M+811.4% | 2.12M | |
| 451M-26.6% | 615M+19.9% | 513M-22.5% | 662M+365.8% | 142M | ||
| Property, plant & equipment | 16.0M-7.8% | 17.3M+0.8% | 17.2M-1.8% | 17.5M+34.6% | 13.0M | |
| Operating lease right-of-use | 45.1M+23.8% | 36.4M+16.0% | 31.4M-10.1% | 34.9M+568.9% | 5.22M | |
| Goodwill | 1.39M+0.0% | 1.39M+0.0% | 1.39M+0.0% | 1.39M+0.0% | 1.39M | |
| Intangible assets | 18.4M+0.0% | 18.4M+0.0% | 18.4M+0.0% | 18.4M+0.0% | 18.4M | |
| Other non-current assets | 47.4M+19.8% | 39.5M+17.0% | 33.8M-9.9% | 37.5M+159.8% | 14.4M | |
| 116M-24.8% | 154M+178.3% | 55.4M-38.4% | 90.0M+114.7% | 41.9M | ||
| Accounts payable | 11.6M-35.4% | 18.0M+15.7% | 15.6M+45.5% | 10.7M+124.1% | 4.78M | |
| Accrued liabilities | 104M+102.6% | 51.5M+29.2% | 39.8M-9.7% | 44.1M+18.7% | 37.2M | |
| Current lease liability | 5.76M+51.4% | 3.80M+14.9% | 3.31M+9.6% | 3.02M+587.7% | 439K | |
| 399M+108.4% | 192M+124.9% | 85.2M-30.7% | 123M+159.7% | 47.4M | ||
| Non-current lease liability | 40.0M+21.9% | 32.8M+18.9% | 27.6M-9.8% | 30.6M+993.4% | 2.80M | |
| Operating lease liability (total) | 45.7M+25.0% | 36.6M+18.5% | 30.9M-8.1% | 33.6M+938.3% | 3.24M | |
| Other non-current liabilities | 4.58M-1.7% | 4.66M+107.7% | 2.25M-6.8% | 2.41M-8.6% | 2.64M | |
| 52.1M-87.7% | 423M-1.1% | 428M-20.6% | 539M+1453.1% | 34.7M+106.7% | ||
| Preferred stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock | 1.93B+16.8% | 1.66B+86.7% | 888M+44.1% | 616M | 0.00 | |
| Additional paid-in capital | 194M+72.6% | 112M+182.3% | 39.8M+187.0% | 13.9M | 0.00 | |
| Retained earnings | -2.08B-54.9% | -1.35B-169.5% | -499M-447.9% | -91.1M | 0.00 | |
| Accumulated other comprehensive income | 8.35M+10467.1% | 79.0K+221.5% | -65.0K-122.9% | 284K | 0.00 | |
| Total equity incl. non-controlling | — | — | — | 539M+1453.1% | 34.7M | |
| Total liabilities & equity | 451M-26.6% | 615M+19.9% | 513M-22.5% | 662M+365.8% | 142M | |
| Common shares issued | 133M+31.2% | 101M+24.8% | 81.1M+19.0% | 68.2M | — | |
| Common shares outstanding | 133M+31.2% | 101M+24.8% | 81.1M+19.0% | 68.2M | — | |
| Shares outstanding (cover) | 150M+47.4% | 102M+25.1% | 81.6M+19.6% | 68.2M | — | |
| Cash Flow | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| -609M-4.6% | -582M-75.6% | -332M-11.4% | -298M-104.1% | -146M-92.0% | ||
| Depreciation & amortization | 9.92M+26.3% | 7.86M+13.6% | 6.91M+398.7% | 1.39M-0.5% | 1.39M+1834.7% | |
| Share-based compensation | 112M+56.1% | 72.0M+150.0% | 28.8M-85.1% | 194M+194.9% | 65.6M+122.5% | |
| Deferred income taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Change in payables | -6.39M-999.4% | 710K-85.4% | 4.87M-17.8% | 5.93M+478.3% | 1.02M+361.7% | |
| 301M+222.7% | -245M-288.7% | 130M+142.6% | -305M-32387.1% | 944K+135.0% | ||
| Capital expenditure | 715K-82.3% | 4.05M+32.8% | 3.05M-49.8% | 6.07M+547.5% | 938K-14.5% | |
| Free cash flow | -610M-4.0% | -587M-75.2% | -335M-10.2% | -304M-107.0% | -147M-90.5% | |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Sales/maturities of investments | 570M+13.0% | 504M+56.6% | 322M | 0.00 | 0.00 | |
| Other investing activities | 1.85M | 0.00 | 0.00 | — | — | |
| 439M-35.2% | 678M+219.8% | 212M-72.4% | 768M+454.4% | 138M-9.1% | ||
| Long-term debt issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long-term debt repaid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock issued | 189M-71.6% | 666M+173.9% | 243M-14.3% | 284M | 0.00 | |
| Common stock repurchased | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividends paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other financing activities | -194K-108.6% | 2.26M | 0.00 | 0.00-100.0% | 395K | |
| FX effect on cash | -3.00K-104.0% | 75.0K+115.1% | -497K-215.9% | 429K | 0.00 | |
| Net change in cash | 130M+187.1% | -150M-1671.9% | 9.52M-94.3% | 166M+2667.0% | -6.45M-108.8% | |
| Interest paid | 216K+72.8% | 125K | 0.00 | 0.00-100.0% | 107K | |
| Income taxes paid | 133K+101.3% | -10.4M+68.6% | -33.3M-187.3% | 38.2M+130.0% | 16.6M+501.7% | |
| Valuation Ratios | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Market cap | 1.70B-55.4% | 3.81B+11.0% | 3.43B+528.3% | 547M | — | |
| P/B | 32.6×+262.3% | 9.0×-24.0% | 11.8×+117.1% | 5.5× | — | |
| Source filing | 10-K | 10-K | 10-K | 10-K | 10-K |
About this data
Source: BHVN’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all BHVN filings on SEC EDGAR → Not investment advice.